1. A direct comparison of long‐ and short‐acting GLP‐1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment. Issue 2 (22nd August 2013) Authors: Gastaldelli, A.; Balas, B.; Ratner, R.; Rosenstock, J.; Charbonnel, B.; Bolli, G. B.; Boldrin, M.; Balena, R. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 2(2014:Feb.) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of lixisenatide once daily vs. placebo in people with Type 2 diabetes insufficiently controlled on metformin (GetGoal‐F1). Issue 2 (24th October 2013) Authors: Bolli, G. B.; Munteanu, M.; Dotsenko, S.; Niemoeller, E.; Boka, G.; Wu, Y.; Hanefeld, M. Journal: Diabetic medicine Issue: Volume 31:Issue 2(2014:Feb.) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12‐month trial including 6‐month extension. Issue 12 (14th September 2015) Authors: Yki‐Järvinen, H.; Bergenstal, R. M.; Bolli, G. B.; Ziemen, M.; Wardecki, M.; Muehlen‐Bartmer, I.; Maroccia, M.; Riddle, M. C. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 12(2015:Dec.) Page Start: 1142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Lixisenatide, a novel GLP‐1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus. Issue 7 (20th January 2014) Authors: Bolli, G. B.; Owens, D. R. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 7(2014:Jul.) Page Start: 588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Modulation of insulin dose titration using a hypoglycaemia‐sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin‐naïve people with type 2 diabetes. Issue 1 (12th July 2014) Authors: Home, P. D.; Bolli, G. B.; Mathieu, C.; Deerochanawong, C.; Landgraf, W.; Candelas, C.; Pilorget, V.; Dain, M.‐P.; Riddle, M. C. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 1(2015:Jan.) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin‐naïve people with type 2 diabetes on oral glucose‐lowering drugs: a randomized controlled trial (EDITION 3). Issue 4 (12th February 2015) Authors: Bolli, G. B.; Riddle, M. C.; Bergenstal, R. M.; Ziemen, M.; Sestakauskas, K.; Goyeau, H.; Home, P. D.; on behalf of the EDITION 3 study investigators Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 4(2015:Apr.) Page Start: 386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1). Issue 4 (1st February 2016) Authors: Matsuhisa, M.; Koyama, M.; Cheng, X.; Takahashi, Y.; Riddle, M. C.; Bolli, G. B.; Hirose, T. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 4(2016) Page Start: 375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2). Issue 4 (21st January 2016) Authors: Terauchi, Y.; Koyama, M.; Cheng, X.; Takahashi, Y.; Riddle, M. C.; Bolli, G. B.; Hirose, T. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 4(2016) Page Start: 366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. One‐year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal‐time insulin: the EDITION 1 12‐month randomized trial, including 6‐month extension. Issue 9 (11th May 2015) Authors: Riddle, M. C.; Yki‐Järvinen, H.; Bolli, G. B.; Ziemen, M.; Muehlen‐Bartmer, I.; Cissokho, S.; Home, P. D. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 9(2015:Sep.) Page Start: 835 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Patient‐level meta‐analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes. Issue 9 (16th June 2015) Authors: Ritzel, R.; Roussel, R.; Bolli, G. B.; Vinet, L.; Brulle‐Wohlhueter, C.; Glezer, S.; Yki‐Järvinen, H. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 9(2015:Sep.) Page Start: 859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗